According to a TASS report, on Tuesday, April 19, the State Duma Committee on Health Protection during its meeting recommended that deputies adopt, in the first reading, a government bill aimed at expanding the possibilities of donated blood supply to drug manufacturers.
The Cabinet of Ministers submitted the document to the State Duma last week. It is proposed to adopt amendments to the laws on donation of blood and its components and on public-private partnership in the Russian Federation. It is proposed to introduce a mechanism for the transfer of blood plasma for the production of medicines in order to increase the volume of “domestic production of plasma medicines classified as vital and essential drugs.”
“According to the bill, blood plasma can be transferred for the production of medicines not only to medical organizations, but also to drug manufacturers unrelated to medical organizations,” the explanatory note to the document reads.
Amendments to previously adopted federal laws will allow for sending donor plasma directly to pharmaceutical plants. Russian manufacturers will receive the necessary components faster, which will enable them to increase capacity and provide drugs that the population needs.
As it became known earlier, the bill prohibits the export of donated blood, its components and plasma obtained in Russia, to other countries, except in cases when it is supplied for humanitarian aid.
